Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001608936-25-000008
Filing Date
2025-10-02
Accepted
2025-10-02 19:18:37
Documents
1
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 form4-10022025_111028.html 4  
1 form4-10022025_111028.xml 4 6215
  Complete submission text file 0001608936-25-000008.txt   7684
Mailing Address C/O IGNYTA, INC. 11095 FLINTKOTE AVE., SUITE D SAN DIEGO CA 92121
Business Address
Chacko Jacob (Reporting) CIK: 0001608936 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 251371539

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)